University Medical Center Groningen
825
148
183
374
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
6.2%
51 terminated/withdrawn out of 825 trials
88.0%
+1.5% vs industry average
11%
93 trials in Phase 3/4
5%
18 of 374 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (825)
Comparative Study on the Mode of Action of Vicadrostat and Spironolactone on Protein Profiles and Renal Hemodynamic Effects (COMPARE-VS)
Role: lead
CANagliflozin In DIALysis Patients
Role: lead
FINE-START: Efficacy and Safety of Finerenone in Patients With Chronic Kidney Disease Not Using Renin-angiotensin-system Inhibitors
Role: lead
Oral Bevacizumab-800CW and Cetuximab-800CW Administration to Detect Early Esophageal Adenocarcinomas
Role: lead
Quantitative Fluorescence Endoscopy Using Durvalumab-680LT in Esophageal Cancer
Role: lead
The SELEQT-HF (SELEnium and CoQ10 NuTrition for Heart Failure) Study Will Evaluate the Effect of Adding Selenium/and coQ10 on Top of Standard HF Therapy in Patients With HF and Will do so Using a Pragmatic, Registry Based Randomized Controlled Trial in the Netherlands.
Role: collaborator
PREVENTion With Sglt-2 Inhibition of Acute Kidney Injury in Intensive Care
Role: collaborator
Empowering Nursing Newcomers Program
Role: lead
Feasibility of Fluorescence Imaging With Bevacizumab-800CW During Bronchoscopy
Role: lead
Virtual Reality Schema Therapy Exercises With Parent and Child Modes
Role: lead
Retrospective Observational Study of Odevixibat Outcomes in Patients With PFIC Versus an External Control Cohort (OvEC-PFIC)
Role: collaborator
Plantar Pressure and Acceptance of the LEEF-shoe in Individuals With Diabetes-related Neuropathy
Role: lead
Transfer of Feces in Ulcerative Colitis 2
Role: collaborator
Coronary Sinus Reducer Therapy for Persisting Angina
Role: collaborator
The Intensive Care Platform Trial
Role: collaborator
Multicenter Registry of Patients With Subarachnoid Hemorrhage
Role: collaborator
Tarlatamab for SCLC Brain Metastases
Role: collaborator
A Study Evaluating the Efficacy of Xanomeline/Trospium (XT) on Cognitive Impairment After 24 and 52 Weeks of Treatment in Adult Participants With Schizophrenia
Role: collaborator
Effects of Communication Training to Involve Older People in Decisions to DEPRESCRIBE Cardiometabolic Medication: a Cluster-randomized Trial in Primary Care
Role: lead
PROSpect: Prone and Oscillation Pediatric Clinical Trial
Role: collaborator